On June 1, 2015, at the 2015 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Jill O'Donnell-Tormey, PhD, Cancer Research Institute's CEO and director of scientific affairs, discussed the latest immunotherapy breakthroughs and what they mean for patients. Panelists were Jedd D. Wolchok, MD, PhD, and Jae Park, MD, both of Memorial Sloan Kettering Cancer Center, and Naiyer A. Rizvi, MD, of Columbia University Medical Center.
Learn the latest news in cancer immunotherapy for melanoma, lung cancer, leukemia, liver cancer, and other cancer types. For more information on immunotherapy, visit www.TheAnswerToCancer.org.
